Volume 680; Issue 1

PharmacoEconomics & Outcomes News

Volume 680; Issue 1
3

European Commission expert panel for containing costs

Year:
2013
Language:
english
File:
PDF, 124 KB
english, 2013
4

Lapatinib dominates in advanced breast cancer

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
5

Velaglucerase-α in type

Year:
2013
Language:
english
File:
PDF, 115 KB
english, 2013
6

Belimumab provides value for money in Hong Kong

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
8

A decade of new cancer drugs: good value for money

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
10

Home telemonitoring favourable in heart failure

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
11

TAVI cost effective in severe AS in the UK

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
12

Denosumab looking good in male osteoporosis

Year:
2013
Language:
english
File:
PDF, 115 KB
english, 2013
13

Targeted use of vemurafenib = low budget impact in Brazil

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
14

Heplisav good hep

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
15

Herd protection a key ingredient in HepA vaccine CEAs

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
16

Fidaxomicin for CDI not cost effective at current cost

Year:
2013
Language:
english
File:
PDF, 128 KB
english, 2013
17

Future government must fix Australia's PBS

Year:
2013
Language:
english
File:
PDF, 128 KB
english, 2013
18

Acute care costly in AD pre-diagnosis

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
19

Oncotype DX assay cost effective in early breast cancer

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
20

Infliximab best choice in plaque psoriasis

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
21

Online drug sales surge in China

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
22

Canadian oncology reimbursements compared

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
23

New guidance from NICE

Year:
2013
Language:
english
File:
PDF, 111 KB
english, 2013
24

Cracks showing in UK government's drug pricing policy

Year:
2013
Language:
english
File:
PDF, 128 KB
english, 2013
25

Intravitreal aflibercept cost effective for wet AMD

Year:
2013
Language:
english
File:
PDF, 112 KB
english, 2013
27

Quadrivalent flu vax tops trivalent vax in the US

Year:
2013
Language:
english
File:
PDF, 112 KB
english, 2013
28

US Medicaid expansion to face tough challenges

Year:
2013
Language:
english
File:
PDF, 112 KB
english, 2013
29

Searching for `best value' first-line HIV antiretrovirals

Year:
2013
Language:
english
File:
PDF, 112 KB
english, 2013
31

Liraglutide LEADs the way for T2DM in China

Year:
2013
Language:
english
File:
PDF, 112 KB
english, 2013
32

Ticagrelor value for money in ACS?

Year:
2013
Language:
english
File:
PDF, 112 KB
english, 2013
35

The patient − at the center of ISPOR

Year:
2013
Language:
english
File:
PDF, 162 KB
english, 2013
36

New oral anticoagulants: cost effective for stroke prevention in AF?

Year:
2013
Language:
english
File:
PDF, 149 KB
english, 2013